Subscribe To
Moleculin (mbrx) posts update from lung cancer study, stock up
Moleculin (MBRX) completes enrollment in the phase II portion of the development program for its lead candid...
September 22, 2023, 9:01 am
Relmada (rlmd) up on positive data for anti-depressant candidate
Relmada's (RLMD) shares rise on long-term efficiency and safety data from the phase III study of its lead cand...
September 21, 2023, 3:02 pm
Prothena: switching from 'hold' to 'buy' on lead alzheimer's drug promise
Prothena Corporation is a protein dysregulation specialist with a focus on developing drugs for Alzheimer's disease. The company's lead ...
September 21, 2023, 1:39 pm
Revolut aims to strengthen digital-age mortgage services
Revolut is on a mission to strengthen its mortgage product offerings for customers across Europe. In a strategic move, the company is expanding its wo...
September 21, 2023, 11:09 am
Does this message from moderna mean bad news for novavax?
Moderna and Novavax both are focused on the coronavirus vaccine market of the future. The two companies each are developing vaccine ...
September 21, 2023, 7:30 am
Frontier portfolio company signs collaboration deal with merck
Frontier IP Group PLC (AIM:FIPP), a firm specialising in the commercialisation of intellectual property, announced in an RNS today that its portfolio ...
September 21, 2023, 4:01 am
Readers post 32 august dividend buy candidates
Prior to August 31, 2023, my Readers mentioned 37 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FA...
September 20, 2023, 4:04 pm
Merck: a blue-chip dividend stock worth buying
Merck & Co., Inc.'s payout ratios suggest that the market-beating dividend is well-covered. The company's stacked portfolio of therapies and ...
September 20, 2023, 12:14 pm
Marinus (mrns) up 20% on financial and pipeline updates
Marinus' (MRNS) shares rise as it provides revenue and cash guidance for third-quarter 2023. The company also updates on the progress of its pipeline ...
September 20, 2023, 10:31 am
Exscientia stock surges on merck kgaa partnership
Exscientia PLC shares climbed as much as 30% in pre-market trading on Wednesday after the precision-medicine company announced a new, multi-year coll...
September 20, 2023, 9:13 am
Exscientia's stock rockets toward a record gain after ai-driven drug discovery collaboration with germany's merck kgaa
The U.S.-listed shares of Exscientia PLC EXAI soared 28.5% toward a record one-day gain, and enough to pace all premarket gainers on major U.S. exchan...
September 20, 2023, 7:50 am
Genflow biosciences primed and ready for phase i/ii trial after regulatory sign-off
Genflow Biosciences PLC (LSE:GENF, OTC:GENFF) said it has received encouraging advice from Belgium's Federal Agency for Medicines and Health Products ...
September 20, 2023, 3:24 am
Up 83% in 5 days, is crinetics pharmaceuticals a buy?
Crinetics Pharmaceuticals' lead candidate could be commercialized soon. It'll have a hard time gaining ...
September 19, 2023, 9:11 am
Cyteir: although the company is winding down, the lead asset had promise
Cyteir is a developer of cancer therapeutics that has decided to suspend operations and sell all assets. Their lead ...
September 18, 2023, 5:32 pm
Vigil neuroscience: interesting early data, wait for phase 2
Vigil Neuroscience is developing medicines for neurodegenerative diseases by restoring microglial function. Their lead ...
September 18, 2023, 2:38 pm
Cellectar biosciences receives european medicines agency priority medicines (prime) designation for iopofosine for waldenstrom’s macroglobulinemia
The EMA’s PRIME status is granted to drug candidates that may offer a major therapeutic advantage ove...
September 18, 2023, 12:40 pm
Elon musk says ‘turkey among most important candidates' for next tesla factory
Recep Tayyip Erdogan – the President of Turkey wants Tesla Inc (NASDAQ: TSLA) to set up its next factory in his country....
September 18, 2023, 11:49 am
Gold forecast – gold prices could explode higher, and soon
Gold is on the launch pad, waiting for a catalyst to send prices soaring. Two potential candidates are ...
September 15, 2023, 1:05 pm
Airbus nears decision on new planemaking leadership - sources
Airbus is pushing ahead with plans to name a new internal head of its commercial aircraft business, effectively recreating a separate civil jetliner d...
September 15, 2023, 12:03 pm
Iovance (iova) up despite fda's delayed decision on melanoma drug
Iovance (IOVA) rises despite the FDA's postponement of the decision date regarding the regulatory filing for its lead ...
September 15, 2023, 9:01 am